Better Therapeutics Inc

NASDAQ:BTTX   3:59:51 PM EDT
1.46
+0.03 (+2.10%)
7:47:20 PM EDT: $1.46 0.00 (0.00%)
Earnings Announcements

Better Therapeutics Reports Third Quarter 2022 Financial Results, Provides Business Updates

Published: 11/14/2022 21:11 GMT
Better Therapeutics Inc (BTTX) - Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates.
Better Therapeutics Inc - on Track to Report Topline Results From Livvita Study in Q4 of 2022.
Better Therapeutics Inc - Qtrly Net Loss per Share $0.48.
Better Therapeutics Inc - Cash and Cash Equivalents Were $22.3 Million on September 30, 2022, Compared to $40.6 Million on December 31, 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.